INTRODUCTION
Actinomycin D (ACTD) is one of the most exhaustively studied DNA-binding ligands and its widespread interest stems from its function as a model sequence-speci®c antitumor antibiotic. It consists of a planar 2-aminophenoxazin-3-one chromophore with two bulky cyclic pentapeptide lactones (Fig. 1) . The drug exerts its biological function via inhibition of transcription in a wide variety of systems. It binds to duplex DNA via intercalation with high af®nity and dissociates slowly from DNA, which had led to a suggested mechanism whereby the drug blocks the progression of RNA polymerase along the template DNA to terminate transcription (1) . The DNA binding of ACTD is quite sequence-speci®c and has been shown to greatly prefer the duplex GpC site. This base-sequence speci®city derives mainly from the formation of strong hydrogen bonds in the minor groove, between the N-2 amino group and N-3 ring nitrogen of the two guanineresidues with the carbonyl oxygen atoms and amide groups of threonine residues of the cyclic peptapeptides, respectively (2, 3) . These essential drug±DNA hydrogen bonds are protected by the cyclic pentapeptides, which effectively shield them from solvent exposure.
The four-base-paired binding site size suggests that the binding characteristic of ACTD to a GpC site may likely be affected by the adjacent¯anking base pairs. Indeed, our studies with self-complementary (4) as well as non-selfcomplementary (5) oligomers containing -XGCY-sites revealed that the binding af®nity for and dissociation kinetics from DNA of this drug are, indeed, greatly affected by the nature of the adjacent X and Y bases. For example, ACTD binds strongly to and dissociates very slowly from the -TGCAsite, whereas it binds weakly and dissociates very rapidly from the -GGCC-sequence (4) . It was subsequently uncovered that, in contrast to oligomers such as d(TATGGCCATA) 2 , the sequence d(CATGGCCATG) 2 binds relatively well to ACTD but with an unusually slow association rate (6) not exhibited by the corresponding oligomers containing strong ACTDbinding tetranucleotide sequences such as -TGCA-, -AGCTand -CGCG-. To account for the observed slow association kinetics, the following model was originally speculated (6) : the conformation of the -GGCC-sequence in d(CATGGCCATG) exists predominantly in a non-standard B-conformation which has a low af®nity for ACTD. Thus, the ACTD molecules initially bind to the decameric duplex via stacking at the terminal G´C base pairs. Their hydrogen bonding interactions with one of the pentapeptide rings at the minor groove result in signi®cant conformational alterations at the central -GGCCsequence to make the intercalative ACTD binding at the GpC site more favorable. The initial binding of drugs, however, has considerably stabilized the duplex so that the rate of base-pair opening to accommodate the drug becomes signi®cantly slower than decamers containing a strong binding -XGCYsequence, and hence the observed order of magnitude slower ACTD association rate.
However, there have been reports to indicate that this drug may also bind strongly to some non-GpC-containing sequences (7±9) and even to some single-stranded DNA (10±15). Subsequent studies led to the ®nding that d(CGTCGTCG) and d(CGACGACG) also bind strongly to ACTD despite the lack of self-complementarity (16) . Most recently it was also discovered that ACTD binds strongly to sequences such as d(TGTCATTG) (17) and d(TGTCATG) (18) with 1:1 drug to strand binding stoichiometry. Basedisplacement binding models of hairpin for the former and slipped duplex for the latter have been proposed, based on the binding principle that both faces of the ACTD chromophore prefer to be stacked by the G-bases (2, 19, 20) . In view of the fact that the oligomer d(CATGGCCATG) contains both the key bases at identical locations (underlined) and CATG sequences present in the two respective strong-ACTD-binding oligomers, a reinvestigation of the observed slow association kinetics exhibited by this sequence appears to be in order and has now been extended to include oligomers of sequence motifs d(CXYGGCCY¢X¢G), where X¢, Y¢ are complementary to X, Y, respectively. The results of these studies and the arrived conclusion are presented herein.
MATERIALS AND METHODS
Synthetic oligonucleotides were purchased from ResGen (Huntsville, AL) and used without further puri®cation. These oligomers were puri®ed by the vendor via reversephase oligonucleotide puri®cation cartridges and exhibited single-band electrophoretic mobility in denaturing polyacrylamide gel electrophoresis with stated purity of b95%. Concentrations of the DNA solutions (in nucleotide) were determined by measuring the absorbances at 260 nm after melting (at 95°C). The extinction coef®cients of DNA oligomers were obtained via nearest-neighbor approximation using mono-and di-nucleotide values tabulated in Fasman (21) . ACTD and 7-amino-ACTD (7AM-ACTD) were purchased from Serva. Concentrations of the drug solutions were determined by measuring the absorbances at 440 nm (for ACTD) and 528 nm (for 7AM-ACTD), using extinction coef®cients of 24 500 and 23 600 cm ±1 M ±1 , respectively. Stock solutions for oligonucleotides and drugs were prepared by dissolving in 10 mM Tris-borate buffer solution of pH 8 containing 0.1 M NaCl and 1 mM MgCl 2 . Absorption spectra were measured with a Cary 1E spectrophotometric system. Absorption spectral titrations were carried out by starting with a 5 mM ACTD solution of 2 ml followed by progressive additions of the oligomer stock at equal time intervals. Absorbance differences between 427 and 480 nm during absorption spectral titrations were used to obtain the binding isotherms. Fluorescence spectra were obtained with a SLM 48000S system. Circular dichroic (CD) spectra were measured at room temperature with a Jasco J-500A recording spectropolarimeter using water-jacketed cylindrical cells of 2-cm path length.
Association binding constants (K) were extracted via nonlinear least-squares ®ts on the experimental binding isotherms using 1:1 drug to strand binding model: D + S = DS, where D, S and DS are free drug, free single-stranded DNA and drug±DNA complex, respectively. By means of equations for the mass balances of drug and DNA (in strand), the following equations can be derived:
where X º S t /D t , e D and e 1 are the extinction coef®cients of the free and bound drugs, and D t and S t are the total drug and DNA strand concentrations, respectively, at each point of the titration. Experimental binding isotherms were plotted as the apparent extinction coef®cient (Y) versus X, and nonlinear least-squares ®ts with the above equations were made by initially ®xing the known e D and subsequently relaxed to obtain the best ®t to extract the binding constant K. Nonlinear least-squares ®t program of Micromath (Salt Lake City, UT) was used for our ®tting purpose. 2 ing 5¢-end shortened heptamers d(GGCCY¢X¢G) are shown in Figure 2 . As is apparent from the more abrupt leveling off, d(GGCCY¢X¢G) oligomers bind considerably stronger to ACTD than their self-complementary parents d(CXYGG-CCY¢X¢G) 2 . A distinct saturation for the heptamers occurring at the DNA strand to drug ratio of~1 strongly suggests a 1:1 drug/strand binding stoichiometry. Thus, the binding isotherms were ®tted with the 1:1 binding model and the nonlinear least-squares ®tted curves are shown as solid lines in the ®gure for comparison. As can be seen, the ®ts for d(GGCCY¢X¢G) are excellent, but less so for their parent decamers. The binding isotherms for the parent decamers d(CXYGGCCY¢X¢G) can be seen to be not as strong and the saturation points not as distinct as their shortened counterparts. The extracted binding constants are in the order of 1 Q 10 7 and 1 Q 10 6 M ±1 for the 7-and 10mers, respectively (see Table 1 ). To provide further insight into the binding mode, studies were also made with d(CXYCGCGY¢X¢G) in which ACTD is expected to bind at the duplex CGCG site. The ACTD binding isotherms for these oligomers were also included in Figure 2 for comparison. It is clearly evident that saturation was de®nitely not reached at the strand/drug ratio of 1 for the CGCG-containing decamers since one drug should be binding to a duplex (two strands). Indeed, curve ®ts with 1:1 Table 1 . Equilibrium titrations were carried out at 25°C and the binding constant K is obtained via nonlinear least-squares ®t to the experimental isotherm using the simple 1:1 drug to strand binding model. T m 0 and T m are the melting temperatures of 40 mM of DNA (in nucleotide) containing 0.1 M NaCl in the absence and in the presence of 8 mM ACTD, respectively. The melting pro®les were obtained via absorbance monitoring for DNA at 275 nm and for DNA±drug complex at 427 nm.
RESULTS

ACTD binds considerably stronger to d(GGCCY¢X¢G) than to d(CXYGGCCY¢X¢G)
drug to strand binding model for these isotherms are apparently not as good.
It is also instructive to compare the Scatchard plots for these three types of oligomers (not shown). To see if the much stronger ACTD binding of d(GGCCY¢X¢G) could be the consequence of reduced self-complementarity for more facile single strand formation, comparative studies of the parent decamers and their corresponding shorter oligomers derived from successive baseremoval from the 5¢-end were also made. Their extracted binding constants via model-®t are summarized in Table 1 . The general trend of progressive increase in ACTD binding af®nity as the sequence is shortened is clearly evident. Dramatic weakening of ACTD binding is observed for oligomers d(CCY¢X¢G) (results not shown) but some af®nities were retained for d(GCCY¢X¢G). Binding constants (in mM ±1 ) of 2.6 T 0.1, 5.1 T 0.2, 1.6 T 0.1 and 0.7 T 0.1 were found for d(GCCTTG), d(GCCATG), d(GCCTAG) and d(GCCAAG), respectively. These can be seen to be between 4-and 14-fold weaker than their d(GGCCY¢X¢G) counterparts (compare with Table 1 ).
Melting temperatures of the drug±DNA complexes are nearly identical for the parent as well as the shortened oligomers
Melting temperatures for these oligomers in the absence (extracted via 275-nm pro®les) and in the presence of ACTD (extracted via 427-nm pro®les) are also included in Table 1 for comparison. As expected, the melting temperature of an oligomer decreases as the sequence becomes shorter as a consequence of the decreased number of possible base pairings for duplex formation. Interestingly, however, the melting temperatures of the drug complexes do not differ greatly, hovering around 62°C for all the oligomers studied. These results suggest that, despite the differing duplex stability, these oligomers may in fact share a common strong ACTD binding mode. Comparison of melting pro®les at 275 and 427 nm suggests additional ACTD binding in the temperature region where DNA duplex is in the process of melting
The melting characteristics of some of these oligomers in the absence and in the presence of ACTD are illustrated in Figure 3 . The melting pro®les with 275-nm monitoring for d(CAAGGCCTTG) and d(CATGGCCATG) are compared with their corresponding shorter heptamers d(GGCCTTG) and d(GGCCATG) in panels A and B, respectively. The predominance of duplex conformations at room temperature for the self-complementary decamers d(CXYGGCCY¢X¢G) is apparent from their melting temperatures of~50°C, whereas those of the heptamers are near 25°C. Despite such vast differences in their duplex stability, however, the melting temperatures of the drug±DNA complexes increased to~62°C (via 427-nm monitoring) for both types of oligomers, but the 275-nm melting pro®les are less cooperative (see Fig. 3A ) and not monophasic (see Fig. 3B ) for the decameric sequences. To provide additional insight into the nature of drug binding, the melting of drug±DNA complex was also monitored by the absorbance changes at 427 nm. Melting pro®les at two different wavelengths for d(CTAGGCCTAG) and d(CTTGGCCAAG) along with their heptameric counterparts are compared in Figure 3C and D, respectively. As expected, the disruption of drug complexes for the heptamers was accompanied by a monophasic melting pro®le of absorbance increase at 427 nm. However, for the drug complexes of the parent decamers the absorbance increase due to the disruption of the complex near 62°C is preceded by an absorbance decrease. The minima of the 427-nm pro®les correspond to the melting regions of the DNA duplexes in the absence of drug (see the melting pro®les with 275-nm monitoring), suggesting additional drug binding upon DNA duplex melting and subsequent disruption of the complex. Similar melting characteristics were also observed for d(CAAGGCCTTG) and d(CATGGCCATG). Such an observation is consistent with the notion that the released drug molecules further bind to single-stranded DNA to accomplish a stronger binding and account for the less cooperative and multiphasic nature of the 275-nm melting pro®les for the drug complexes.
Association kinetic studies via¯uorescence monitoring
Although ACTD is only slightly¯uorescent, its 7-amino derivative is strongly so and it is known that the amino group substitution does not greatly alter the intercalative binding nature of this derivative. Thus,¯uorescence spectral alteration upon DNA binding can provide additional insight into the binding processes. The emission spectral characteristics of 7AM-ACTD in the absence and in the presence of d(CTAGGCCTAG) are compared in Figure 4A . The emission spectrum of the drug exhibits intensity maximum at~660 nm with excitation at 560 nm. In the presence of DNA oligomer, however, intensity enhancement and depression are observed in the region of 600 and 660 nm, respectively. Thus, association kinetic behavior of drug binding to these oligomers can be investigated by monitoring the¯uorescence intensity changes at these spectral regions.
The association kinetic traces of¯uorescence at 600 and 660 nm with 560 nm excitation for 7AM-ACTD binding to d(CTAGGCCTAG) at 20°C are shown in Figure 4B . As can be seen, a signi®cant intensity enhancement with slow kinetics is observed at 600 nm and the biphasic nature of the kinetic trace is clearly evident, with a fast component being followed by a considerably slower process. Nonlinear least-squares ®t led to the extraction of two rate constants of 0.11 and 0.0024 s ±1 , or characteristic times of 9.1 and 420 s, respectively. The biphasic nature of the kinetic process can be more dramatically illustrated by monitoring the emission intensity at 660 nm upon DNA binding (Fig. 4B) . The kinetic trace at this wavelength exhibits an initial burst of intensity enhancement followed by a much slower decay with intensity reduction. To provide further insight into the nature of the binding processes, studies were also made with d(ATA-GGCCTAT) where the terminal C and G bases have been replaced by A and T, respectively. Only the fast process was observed, with the apparent absence of the slow kinetic component (Fig. 4B) . Single-exponential ®t led to a rate constant of 0.13 s ±1 , or a characteristic time of~8 s, a value akin to the observed fast component of the d(CTAGGCC-TAG) duplex. Thus, it is apparent that the fast kinetic process can reasonably be associated with the initial drug binding at the GGCC site of d(CTAGGCCTAG) and that the presence of the terminal G base at the 3¢-end (see later) appears to be responsible for the presence of the slow kinetic behavior.
Fluorescence spectral comparison
Fluorescence difference spectra for 7AM-ACTD in the absence and in the presence of d(CXYCGCGY¢X¢G), d(CXYGGCCY¢X¢G) and d(GGCCY¢X¢G) are compared in Figure 5 . Binding of the drug to d(CXYCGCGY¢X¢G) results in only a weak intensity reduction near 650 nm. On the other hand, the drug binding to d(GGCCY¢X¢G) resulted in not only a strong¯uorescence intensity reduction near 620 nm but also a concomitant intensity enhancement around 580 nm. Interestingly, aside from the considerably reduced intensity, the difference¯uorescence spectra for d 
DISCUSSION
The near identical melting temperatures exhibited by the drug complexes of self-complementary decamers d(CXYGGC-CY¢X¢G) as well as their 5¢-end truncated oligomers suggest that these sequences likely share a common strong binding mode, a notion also supported by their similar induced uorescence spectral characteristics. The stronger ACTD Figure 7 .
For the parent self-complementary decamers in solution, the duplex conformation will be the predominant form. Thus, the majority of added drug molecules will initially bind to the central GpC site, contributing to the fast kinetic process, though some will bind to the single-stranded form as a hairpin and/or a slipped duplex. Contributions from the slipped duplexes are expected to be rather minor due to the greatly reduced number of base pair formations as well as the very dilute concentrations in our optical experiments. Due to the stronger binding of the hairpin form, the equilibrium between the duplex and single strands will be shifted to the side of single strand for further binding as hairpins to establish new equilibrium, thus contributing to the observed slower kinetic process. Such a kinetic scheme is supported by the ®nding that only a fast kinetic process and low af®nity are observed for 7AM-ACTD binding to d(ATAGGCCTAT), where no G base is present at the 3¢-terminus for possible fold-back hairpin formation for the strong drug binding. The absence of the slow kinetic component for the heptamers d(GGCCY¢X¢G) (results not shown) on the other hand, can be attributed to the predominance of the single-stranded form of these oligomers in solutions with little need for the duplex disruption to achieve the strong drug binding to form the hairpin complex.
The most likely hairpin conformation is for the 3¢-terminus G to fold back and base-pair with the C base of the GGC to result in a hairpin with a CY¢X¢ loop, since the other G´C basepair formation will result in a two-base loop which will be energetically less feasible. The obvious binding will then be for the ACTD chromophore to insert at the GpC site so that one side of the phenoxazone ring will be stacked by a G and the other side by the C´G base pair. However, a similar basestacking pattern can also be accomplished by¯ipping out the central G of the GGC sequence. Such a binding mode and its unusual stability is akin to what had earlier been proposed for the strong single strand binding of sequence motifs such as d(TGTCATTG) (17) and d(TGTCT n G) (22) . Such a hairpinbinding mode with displaced base(s) to accomplish both sides of the phenoxazone ring of ACTD being stacked by 3¢-sides of G bases have been con®rmed by NMR studies on d(GXCACCGYC) sequence motifs, where X and Y are complementary to each other (23) . These oligomers form hairpins with ACC loops to result in the formation of 5¢-GXC/ CYG-5¢ duplex stems. The loop-out X/Y bases upon ACTD binding, however, are not disordered but interact perpendicularly with the base/chromophore and form speci®c hydrogen bonds with DNA, thus contributing to the added stability of the complex.
The¯ipped-base hairpin binding mode appears to be favored, as evidenced by the observed stronger ACTD binding af®nities of d(GGCCY¢X¢G) as compared to those of d(GCCY¢X¢G) where the binding is expected to be at the GpC site. The structural bases for the stronger binding for the base-displaced complex can be justi®ed from the NMR results on the d(G 1 G 2 C 3 A 4 C 5 C 6 G 7 C 8 C 9 ) oligomer that forms a hairpin with the 5¢-G 1 G 2 C 3 /C 9 C 8 G 7 -5¢ duplex stem and ACC loop (23) . Thus, one would expect ACTD to insert at the GpC site to form the classic intercalation complex, yet the NMR measurements indicate a predominant binding mode of disrupting the central G´C base pair to accommodate the phenoxazone ring insertion. The looped-out G 2 /C 8 residue in the complex does not change the G 1 /phenoxazone/G 7 stacking core and the hydrogen bonding between the DNA guanines and the ACTD-L-Thr residues. The two looped-out perpendicular G 2 /C 8 bases do interact well with the ACTD phenoxazone 6CH 3 and 4CH 3 groups and also participate in perpendicular interaction with the G 1 /phenoxazone/G 7 stacking core in the major groove. Furthermore, hydrogen bonds between the C 8 NH 2 -G 7 PO5¢ atoms and the phenoxazone-2 NH 2 -G 2 O4¢ atoms are also observed. Altogether, these factors may explain the extraordinary stability of this kind of complex and make plausible our proposed kinetic scheme on ACTD binding to DNA of the self-complementary sequence motifs d(CXYGGCCY¢X¢G).
Finally, our preliminary NMR studies did indicate that the addition of ACTD to the 5¢-GGCCATG-3¢ oligomer strongly induces the structural formation of the seemingly single-stranded DNA oligomer (Chou,S.-H., Chin,K.-H. and Chen,F.-M., unpublished results). Detailed NMR studies on such a complex are currently underway and will be reported at a later date.
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